Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 577 of 1,261
  1. US 9919056

    Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

    ADC THERAPEUTICS SA · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  2. US 9919040

    Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  3. US 9920320

    Methods of modulating compliance of the trabecular meshwork

    The Regents of the University of California · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  4. US 9914763

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  5. US 9914773

    Anti-human folate receptor beta antibodies and methods of use

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  6. US 9915668

    Antibody based reagents that specifically recognize toxic oligomeric forms of tau

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  7. US 9913841

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  8. US 9914940

    Targeted integration into the PPP1R12C locus

    Sangamo Therapeutics, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  9. US 9913461

    Genetically modified mouse whose genome comprises a humanized CD274 gene

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  10. US 9913909

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  11. US 9913869

    Formulations comprising herbal extracts

    MONTERO GIDA SANAYI VE TICARET A.S. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  12. US 9913892

    Materials and methods for respiratory disease control in canines

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  13. US 9914723

    Small molecule inhibitors of Mcl-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  14. US 9914927

    RNAi inhibition of alpha-ENaC expression

    Arrowhead Pharmaceuticals, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  15. US 9914775

    Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels

    The Board of Regents of the University of Texas System · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  16. US 9914765

    WAP domain fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  17. US 9914774

    Notch pathway inhibition

    The Regents of the University of California · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  18. US 9913900

    Method of treating alvelor bone loss through the use of anti-sclerostin antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  19. US 9913910

    Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

    Heron Therapeutics, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  20. US 9913913

    Method for preparing a polymeric reagent

    Nektar Therapeutics · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  21. US 9913885

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  22. US 9913843

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  23. US 9913842

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  24. US 9913833

    Methods of treating developmental disorders using pipradrol

    OVID THERAPEUTICS INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.